BILLS-117hres589ih.pdf
House Resolutions
0 pages
Page
of 0
Loading OCR text...
No OCR text available for this page.
Failed to load OCR text.
DATE (5)
23:37 Aug 17, 2021
42 U.S.C. 355–1(a)(1
April 12, 2021
AUGUST 17, 2021
May 7, 2021
EVENT (1)
SESSION
H.
FAC (4)
PO 00000
Frm 00003
Fmt
PO 00000
Frm 00002
PO 00000
Frm 00001
PO 00000
Frm 00004
GPE (11)
the United States
Illinois
Florida
California
Texas
New
York
Georgia
Washington
KELLY
IH
New York
NORP (1)
American
ORG (19)
DSK79L0C42PROD
REMS
FDA
Congress
the Federal Food, Drug
Risk Evaluation and Mitigation Strategies
Ms.
the Federal
Food, Drug
State
the Committee on Energy and Commerce
Academy of Family Physicians
the House of Representatives
the American Medical Association
House
the Food and Drug Admin-
the World Health Organization
the American College of Obstetricians
PERSON (50)
kjohnson
BLUMENAUER
TORRES
JACKSON
MANNING
ADAMS
LEE
TONKO
WELCH
WILSON
WATSON
COLEMAN
AUCHINCLOSS
QUIGLEY
NAPOLITANO
EVANS
PRESSLEY
CLARKE
VEASEY
DELBENE
SCHAKOWSKY
SMITH
POCAN
DESAULNIER
TRONE
DEAN
CASTOR
BONAMICI
VARGAS
SCHIFF
NADLER
OMAR
HUFFMAN
JONES
CAROLYN B. MALONEY
CONNOLLY
BASS
RICE
KHANNA
WILLIAMS
CHU
BUSH
LIEU
FOSTER
LOIS FRANKEL
KILMER
ESPAILLAT
GARCIA
DANNY K. DAVIS
COOPER
SARBANES
Topic Classifications
congressional legislation
97.9%
government oversight
82.6%
public health
78.5%
Extracted Keywords
mifepristone
fda
abortion care
medication
abortion
restrictions
patients
drug
governing
harmed
care verdate
incomes
care
unnecessary
food drug
Forensic Analysis
PDF Metadata
- Creator
- U.S. Gov. Printing Office -- G.S.D.D.
- ModDate
- D:20221229202527Z
- Producer
- Acrobat Distiller 21.0 (Windows); modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
- CreationDate
- D:20210818001836-04'00'
Sentiment
Polarity
Neutral
0.083
Subjectivity
45%
Objective